Rasonque (daraxonrasib) NDC 24538-435

NDC codes

FDA NDC Directory

Product NDC (as listed)24538-435Labeler and product segments. Claims need a package NDC.

Product NDC at billing width24538-0435Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
24538-435-01	24538043501	30 mg in 1 BOTTLE (24538-435-01)Marketed from Aug 26, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rasonque
Generic name (nonproprietary): daraxonrasib
Active ingredients: Daraxonrasib — 150 mg/150mg
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Shanghai SynTheAll Pharmaceutical Co., Ltd.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 220910
Marketing start: Aug 26, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 24538-435_5ba7bafa-646f-dc57-e063-6394a90a4a33SPL ID 5ba7bafa-646f-dc57-e063-6394a90a4a33

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N424538043501 followed by a unit qualifier and the quantity

Package 24538-0435-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

Other NDCs under NDA 220910

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 220910
Product	Strength	Form · route	Labeler	Product NDC
Rasonquedaraxonrasib	Daraxonrasib 100 mg/1	Tablet, Film coatedOral	Revolution Medicines, Inc.	85219-101
Rasonquedaraxonrasib	Daraxonrasib 150 mg/1	Tablet, Film coatedOral	Revolution Medicines, Inc.	85219-104
Rasonquedaraxonrasib	Daraxonrasib 100 mg/100mg	Tablet, Film coatedOral	Shanghai SynTheAll Pharmaceutical Co., Ltd.	24538-430